e.g. mhealth
Search Results (1 to 10 of 21 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 6 JMIR Formative Research
- 4 Journal of Medical Internet Research
- 3 JMIR Research Protocols
- 2 JMIR Medical Informatics
- 1 JMIR AI
- 1 JMIR Aging
- 1 JMIR Cardio
- 1 JMIR Mental Health
- 1 JMIR Perioperative Medicine
- 1 JMIR mHealth and uHealth
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Public Health and Surveillance
- 0 JMIR Serious Games
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Readmission is an unintended outcome that occurs in patients discharged from the hospital. In South Korea, the 30-day readmission rate in tertiary general hospitals in 2020 was approximately 30%, increasing yearly along with readmission cost statistics [1]. According to a Center for Medicare and Medicaid Services report in the United States, readmission rates for patients reach 2 million yearly, with readmissions costing $26 billion [2].
JMIR Med Inform 2025;13:e56671
Download Citation: END BibTex RIS
Across all diagnoses, admission carried a significantly greater adjusted risk than a discharge of 30-day readmission (RD=5.8%, 95% CI 5.0 to 6.5). Individual diagnoses yielded adjusted estimates in the same direction as that of the entire sample, but the magnitude was notably larger in a few cases. For patients with weakness, admission carried a greater adjusted risk than a discharge 30-day readmission (RD=61.6%, 95% CI 57.7 to 65.5).
JMIR Aging 2025;8:e55929
Download Citation: END BibTex RIS
Predictive Modeling of Hypertension-Related Postpartum Readmission: Retrospective Cohort Analysis
All-cause hospital readmission rates are on the rise with risk factors for all-cause postpartum readmission including public insurance, race, presence of comorbid conditions including hypertension and diabetes, and cesarean section [3].
JMIR AI 2024;3:e48588
Download Citation: END BibTex RIS
This includes those who received ICU treatment, high-risk discharges, and patients with thoracic and cardiovascular conditions with high readmission rates. The primary goal is to monitor disease control status, medication adherence, vital sign changes, and self-care ability.
JMIR Form Res 2024;8:e53455
Download Citation: END BibTex RIS
To the best of our knowledge, to date, no study exists that applied ML to only outpatient SHI data to predict all-cause readmission in HF.
The aims of this study were (1) to evaluate the use of outpatient SHI data to predict 1-year all-cause (primary end point) and HF-specific (secondary end point) readmission after an initial admission for HF and (2) to identify and rank relevant predictors for readmission.
JMIR Cardio 2024;8:e54994
Download Citation: END BibTex RIS
Discharge coordination (DC) has been tested for years, especially in North America and Japan, to reduce the rate of readmission within 30 days, also with mixed results [18-20]. In Europe, concerns over readmission rates are less of a financial concern, but the same lack of coordination issue at discharge remains [21]. Diseases and related treatments are becoming increasingly complex, and multimorbidities represent a challenge in coordination.
JMIR Form Res 2024;8:e51728
Download Citation: END BibTex RIS
In terms of treated cases, the readmission rate was 9.07% (1222/13,477). The rates increased to 17.1% (1542/9016) for patients and 18.85% (1975/10,478) for cases when considering a longer time horizon for the readmission (90 days). Readmission rates were generally higher in the intervention group (80/705, 11.3%) at 30 days and 28.8% (161/560 at 90 days) than in the hospital as a whole and the control group.
J Med Internet Res 2024;26:e47133
Download Citation: END BibTex RIS
While this readmission risk underscores that patients receive life-saving care, it also encompasses implications of health care costs, patient’s stress, and the impact of socioeconomic determinants on care outcomes [2]. The risk of readmission due to the worsening of HF symptoms is heightened by inappropriate treatment strategies, infectious complications, or prematurely executed discharges.
JMIR Res Protoc 2024;13:e52744
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Readmission rates are a part of the value-based purchasing program, and depending on the readmission rate, hospitals are penalized on a yearly basis, hence impacting hospital costs [28]. The readmission rates were measured for 6 conditions or procedures, as patients with these conditions are more likely to be readmitted to the hospital.
JMIR Med Inform 2024;12:e52524
Download Citation: END BibTex RIS